Search

Your search keyword '"Hatala R"' showing total 401 results

Search Constraints

Start Over You searched for: Author "Hatala R" Remove constraint Author: "Hatala R"
401 results on '"Hatala R"'

Search Results

53. The Importance of ECG Offset Correction for Premature Ventricular Contraction Origin Localization from Clinical Data

54. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

55. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

56. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

59. Linee guida ESC 2015 per il trattamento dei pazienti con aritmie ventricolari e la prevenzione della morte cardiaca improvvisa: Task Force per il Trattamento dei Pazienti con Aritmie Ventricolari e la Prevenzione della Morte Cardiaca Improvvisa della Società Europea di Cardiologia (ESC)

63. Screening for Atrial Fibrillation

65. 2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation [Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012]

66. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

67. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The euro heart survey

68. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on atrial fibrillation

69. Wytyczne ESC dotyczące postępowania u pacjentów z komorowymi zaburzeniami rytmu oraz zapobiegania nagłym zgonom sercowym w 2015 roku

70. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

71. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart

72. Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation

74. Atrial fibrillation management: A prospective survey in ESC Member Countries - The Euro Heart Survey on atrial fibrillation

75. Manažment pacientov s rizikom náhlej kardiálnej smrti.

76. Clinical Profile and Angiographic Findings among Patients with Atrial Fibrillation Presenting for Selective Coronary Angiography

77. Actualización de las guías de la Sociedad Europea de Cardiología (ESC) para el manejo de la fibrilación auricular de 2010 Elaborada en colaboración con la Asociación Europea del Ritmo Cardiaco

78. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation

79. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association

80. Management of patients receiving implantable cardiac defibrillator shocks

82. 5A.03

84. Variations of heart rate variability parameters prior to the onset of ventricular tachyarrhythmia and sinus tachycardia in ICD patients. Results from the heart rate variability analysis with automated ICDs (HAWAI) registry

85. Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe. A Report From the Euro Heart Survey on Atrial Fibrillation

86. Assessment of left ventricular arrhythmogenic substrate in patients with ischemic heart disease by cardiac magnetic resonance.

87. Manažment akútnych koronárnych syndrómov na Slovensku v roku 2015. Aktuálne analýzy registra SLOVAKS.

89. Clinical Implementation of Cardiac Resynchronization Therapy—Regional Disparities across Selected ESC Member Countries

90. Actualización de las guías de la Sociedad Europea de Cardiología (ESC) para el manejo de la fibrilación auricular de 2010 Elaborada en colaboración con la Asociación Europea del Ritmo Cardiaco.

92. Main Session: Gap junctions in myocardial disease

93. 54. Assessing cardiac physical examination competence using simulation technology and real patientss

94. 59. General medicine residents' perception of the mini-CEXs

95. Oxidative stress after pulmonary veins isolation: Deteriorative or protective factor?

96. Oxidačný stres po izolácii pľúcnych žíl: Deterioračný alebo protektívny faktor?

99. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference

100. Poster Session 3

Catalog

Books, media, physical & digital resources